Description
HIV protease substrate ARVLAEA is a peptide binding epitope of the capsid CA-p2 cleavage site.
| Product Unit Size | Cost | Quantity | Stock |
|---|
HIV protease substrate ARVLAEA is a peptide binding epitope of the capsid CA-p2 cleavage site.
| Purity | ≥98% |
|---|---|
| Formula | C33H59N11O10 |
| Formula Wt. | 769.90 |
| Solubility | Soluble in water (2 mg/mL), acetonitrile. |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
Prabu-Jeyabalan M, Nalivaika E, Schiffer CA. How does a symmetric dimer recognize an asymmetric substrate? A substrate complex of HIV-1 protease. J Mol Biol. 2000 Sep 1;301(5):1207-20. PMID: 10966816.
RIP1 inhibitor.
Endogenous peptide, involved in stress signalin...
Imidazoquinoline nucleoside analog; TLR-7/8 ago...
Thio sulforaphane analog, ITC.
CysLT1 antagonist.
Benzimidazole; microtubule polymerization inhib...
5-HT1B/1D agonist.
Diterpene originally found in Rabdosia.
Synthetic peptide, vasopressin analog; AVPR1 ag...
B cell epitope found on hepatitis B viral core ...
Aldose reductase inhibitor.
Roscovitine analog; CDK inhibitor.
Everolimus impurity
Peptide, GnRH analog.
EGFR, VEGFR inhibitor.
Imidazole; 14-α demethylase inhibitor, potenti...
Tetracycline; protein translation inhibitor, MM...
Isoflavonoid found in Glycyrrhiza; GABA-A posit...
Inhibitor of Abl, c-Kit, and PDGFR.
Imidazole; PPARγ agonist, RORγ inverse agonis...